NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010



Similar documents
Hematology Morphology Critique

A Clinical Pathology 201 Study Module

EDUCATIONAL COMMENTARY - GRANULOCYTE FORMATION AND CHRONIC MYELOCYTIC LEUKEMIA

Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran ABNORMAL MORPHOLOGY OF BLOOD CELLS

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Exercise 9: Blood. Readings: Silverthorn 5 th ed, , ; 6 th ed, ,

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015

Evaluation of Cell Morphology and Introduction to Platelet and White Blood Cell Morphology

MORPHOLOGIC ABNORMALITIES OF THE ERYTHROCYTE

Atlas of Hematology and Analysis of Peripheral Blood Smears

Pathology No: SHS-CASE No. Date of Procedure: Client Name Address

ABO-Rh Blood Typing Using Neo/BLOOD

STAINING OF PBF AND INTERPRETATION OF NORMAL AND ABNORMAL RED CELL MORPHOLOGY

Leukemias and Lymphomas: A primer

Laboratory 12 Blood Cells

HM_09_336 v1.0. Atlas of Pediatric Peripheral Blood Smears

Blood. Functions of Blood. Components of Blood. Transporting. Distributing body heat. A type of connective tissue. Formed elements.

Hematology Sequence. Blood Labs ORIENTATION OBJECTIVES. c. Microscopic Exam of a Peripheral Blood Smear (several parts)

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

Cardiovascular System. Blood Components

Preparation of Blood Films

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood

ABO-Rh Blood Typing With Synthetic Blood

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

White Blood Cells (WBCs) or Leukocytes

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

BLOOD-Chp. Chp.. 6 What are the functions of blood? What is the composition of blood? 3 major types of plasma proteins

RDW-- Interpreting the Full Blood Count

Emerging New Prognostic Scoring Systems in Myelodysplastic Syndromes 2012

What Does My Bone Marrow Do?

Subtypes of AML follow branches of myeloid development, making the FAB classificaoon relaovely simple to understand.

Anemia and Leukocytosis Answers

Granulocytes vs. Agranulocytes

LABORATORY 2 Staining and processing of blood parasites Differential counts of leukocytes (giemsa stains)

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Acute myeloid leukemia (AML)

Acute Myeloid Leukemia

Lab 02: Blood Cytology (20 points)

Phlebotomy Handbook Blood Collection Essentials Seventh Edition

EVALUATING BLOOD FILMS

Laboratory Studies in the Diagnosis of Iron Deficiency, Latent Iron Deficiency and Iron Deficient Erythropoiesis

BLOOD FILM STAINING EFFECTS

California Association for Medical Laboratory Technology Distance Learning Program

3. The Circulatory System

XE-2100 Automated Hematology System. Fast, Accurate, Dependable

Stem Cell Transplantation

Keywords: RBC histogram, Peripheral blood smear, red cell disorders.

ACUTE MYELOID LEUKEMIA (AML),

Hematopathology VII Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, And Hairy Cell Leukemia

Human Anatomy & Physiology II with Dr. Hubley

Response Definition, Evaluation and Monitoring. Michele Baccarani

Young fetus: site of hematopoiesis together with the liver and bone marrow. Hgb WBC > < Plt Hct. Retic =

Please list four delivery functions of blood, two regulatory functions, and two protection functions. Delivery (distribution) functions

Acute myeloid leukaemia (AML) in children

Myelodysplasia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia Plasma Cell (Multiple) Myeloma

Complete Blood Count in Primary Care

3 PART ONE: The Principles of Hematology PART TWO: Erythrocytes 89 5

Processing & Utilization of Cord Blood for Transplant

EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE

Essentials of Anatomy and Physiology, 9e (Marieb) Chapter 10 Blood. Short Answer. Figure 10.1

AUTOMATED CLASSIFICATION OF BLASTS IN ACUTE LEUKEMIA BLOOD SAMPLES USING HMLP NETWORK

Cytogenetics for the Rest of Us: A Primer

HISTOLOGY LABORATORY. Microscope Orientation and Blood Smear Lab

Interpretation of Laboratory Values

Methodology for Automatic Classification of Atypical Lymphoid Cells from Peripheral Blood Cell Images

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM

Hepatitis C. Laboratory Tests and Hepatitis C

Leukemia Acute Myeloid (Myelogenous)

Professor Emeritus Paul J Canfield Faculty of Veterinary Science University of Sydney HAEMATOLOGY PRACTICAL NOTES FOR VETERINARY NURSES INTRODUCTION

serology Agglutination Techniques and Blood Cell Identification

Childhood Leukemia. Normal bone marrow, blood, and lymphoid tissue

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions.

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Understanding Leukemia

A.L. Wafa a sameer 2014 Circulatory system / Physiology. Physiology of blood

A&P 2 Blood Lab Guide In-Lab Exercises

LAB: Blood Exploration

Controversies in the management of patients with PMF 0/1


Haematology what does your blood test mean?

SEED Haematology. Sysmex Educational Enhancement and Development February 2013

Blood Cell Identification: 2010-C Mailing: Hemoglobin SC Disease CASE HISTORY DISCUSSION NORMAL ADULT HEMOGLOBIN

PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA

Key Words: Erythrocytes, reticulocytes, neutrophils, eosinophils, basophils, monocytes, lymphocytes, platelets, CBC

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO Gundersen Health System Center for Cancer and

for Leucocyte Immunophenotyping Leukaemia Diagnosis Interpretation All Participants Date Issued: 08-September-2014 Closing Date: 26-September-2014

My Sister s s Keeper. Science Background Talk

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank

Things You Don t Want to Miss in Multiple Myeloma

National Cancer Institute

MEDICAL COVERAGE POLICY

Albumin. Prothrombin time. Total protein

And Now, Presenting...

Chronic Lymphocytic Leukemia. Case Study. AAIM Triennial October 2012 Susan Sokoloski, M.D.

Oncology Best Practice Documentation

Transcription:

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010 Slide 081 Available data: 72 year-old female Diagnosis: MDS to AML WBC 51.0 x 10 9 /L RBC 3.39 x 10 12 /L Hemoglobin 9.6 g/dl Hematocrit 29.1 % MCV 86.0 fl Platelet count 16 x 10 9 /L The significant finding in this case of Acute Myelogenous Leukemia (AML) was the presence of many blast forms. The participant median for blasts, all types was 88. The blast cells in this case (Image 081) are large, irregular in shape and contain large prominent nucleoli. It is difficult to identify a blast cell as a myeloblast without the presence of an Auer rod in the cytoplasm. Auer rods were reported by three participants. Two systems are used to classify AML into subtypes, the French- American-British (FAB) and the World Health Organization (WHO). Most are familiar with the FAB classification. The WHO classification system takes into consideration prognostic factors in classifying AML. These factors include cytogenetic test results, patient s age, white blood cell count, pre-existing blood disorders and a history of treatment with chemotherapy and/or radiation therapy for a prior cancer. The platelet count in this case was 16,000. Reduced number of platelets was correctly reported by 346 (94%) of participants. Approximately eight percent of participants commented that the red blood cells in this case were difficult to evaluate due to the presence of a bluish hue around the red blood cells. Comments received included, On slide 081 the morphology was difficult to evaluate since there was a large amount of protein surrounding RBC s, Slide 081 unable to distinguish red cell morphology due to protein and Unable to adequately assess morphology on slide 081 due to poor stain. Cell staining varies from case to case depending on the pathologic condition and the staining process. If the quality of a smear does not meet your laboratory standard, good laboratory practice would indicate preparation of a new smear and/or adjustment to the staining process. If the change does not resolve the issue, it would be appropriate to comment on the inability to assess red cell morphology as did 28 participants in this event. Participant results for red blood cell morphology are included in the report but these were not evaluated.

Slide: 081 Cell Classification or Finding Expected Range Participant Median Participant Range Blast cell not classified 0-96 88 0-96 Myeloblast/Promyelocyte 0-0 0 0-0 Lymphoblast/Prolymphocyte 0-85 0 0-87 Monoblast/Promonocyte 0-0 0 0-0 Erythroblast 0-0 0 0-0 *[Blasts, all types] 43-96 88 20-96 Lymphoma/Sezary cell 0-0 0 0-0 Hairy cell 0-0 0 0-0 Myelocyte 0-0 0 0-0 Metamyelocyte 0-0 0 0-0 Band neutrophil 0-1 0 0-1 Segmented neutrophil 0-8 4 0-8 *[Total neutrophils] 0-8 4 0-9 Eosinophil 0-0 0 0-1 Basophil 0-1 0 0-1 Lymphocyte 0-26 4 0-28 Atypical lymphocyte 0-4 0 0-5 Monocyte 0-7 2 0-7 Plasma cell 0-0 0 0-0 NRBC / 100 WBC 0-1 0 0-1 Cell Classification or Finding Expected Result Participant Results Anisocytosis None None ( 28%) Slight ( 63%) Moderate (9%) MarKed ( 0%) Poikilocytosis None None ( 59%) Slight ( 38%) Moderate (3%) MarKed ( 0%) Macrocytosis None None ( 88%) Slight ( 11%) Moderate (1%) MarKed ( 0%) Microcytosis None None ( 76%) Slight ( 22%) Moderate (2%) MarKed ( 0%) Hypochromia None None ( 57%) Slight ( 32%) Moderate (9%) MarKed ( 1%) Polychromasia None None ( 89%) Slight ( 11%) Moderate (0%) MarKed ( 0%) Reduced number of platelets Present Absent( 6%) Present( 94%) Increased number of platelets Absent Absent(100%) Present( 0%) Phagocytosis of platelet(s) Absent Absent(100%) Present( 0%) Bizarre or irregular platelets Absent Absent( 99%) Present( 1%) Clumped platelets Absent Absent( 97%) Present( 3%) Giant platelets Absent Absent( 97%) Present( 3%) Platelet satellitosis Absent Absent(100%) Present( 0%) Auer rods Absent Absent( 99%) Present( 1%) Dohle bodies Absent Absent(100%) Present( 0%) Hypersegmentation Absent Absent( 99%) Present( 1%) Pelger Huet anomaly Absent Absent(100%) Present( 0%) Smudge / Basket cells Absent Absent( 58%) Present( 42%) Toxic granulation Absent Absent( 99%) Present( 1%) Acanthocytes Absent Absent( 98%) Present( 2%) Basophilic stippling Absent Absent( 96%) Present( 4%) Blister cells (pre keratocytes Absent Absent(100%) Present( 0%) Cabot rings Absent Absent(100%) Present( 0%) Echinocytes (crenated/burr cells) Absent Absent( 79%) Present( 21%) Elliptocytes (ovalocytes Absent Absent( 83%) Present( 17%) Howell-Jolly bodies Absent Absent(100%) Present( 0%) Pappenheimer bodies Absent Absent(100%) Present( 0%) Red cell agglutinates Absent Absent(100%) Present( 0%) Rouleaux Absent Absent( 96%) Present( 4%) Schistocytes Absent Absent( 90%) Present( 10%) Schuffner's granules Absent Absent(100%) Present( 0%) Sickle cells (drepanocytes0 Absent Absent(100%) Present( 0%) Spherocytes Absent Absent( 96%) Present( 4%) Stomatocytes Absent Absent(100%) Present( 0%) Target cells (codocytes) Absent Absent(100%) Present( 0%) Tear drop cells (dacrocytes) Absent Absent( 99%) Present( 1%) Bacteria Absent Absent(100%) Present( 0%) Fungi/yeast Absent Absent(100%) Present( 0%) Malaria/Babesiosis Absent Absent(100%) Present( 0%) Stain precipitate Absent Absent( 97%) Present( 3%) Phagocytosis of red cell(s) Absent Absent(100%) Present( 0%) * Obtained by combining individual results

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010 Slide 082 Available data: 46 year-old female Diagnosis: Asymptomatic WBC 7.1 x 10 9 /L RBC 4.56 x 10 12 /L Hemoglobin 13.5 g/dl Hematocrit 40.1 % MCV 88.0 fl Platelet count 267 x 10 9 /L Image 082 was taken from a case of an asymptomatic female, the hematologic findings are unremarkable. The red blood cells are normochromic and normocytic. Although there are no abnormal white blood cells present in this case, three participants reported the presence of plasma cells and appropriately received an evaluation of Unacceptable.

Slide: 082 Cell Classification or Finding Expected Range Participant Median Participant Range Blast cell not classified 0-0 0 0-0 Myeloblast/Promyelocyte 0-0 0 0-0 Lymphoblast/Prolymphocyte 0-0 0 0-0 Monoblast/Promonocyte 0-0 0 0-0 Erythroblast 0-0 0 0-0 Lymphoma/Sezary cell 0-0 0 0-0 Hairy cell 0-0 0 0-0 Myelocyte 0-0 0 0-0 Metamyelocyte 0-0 0 0-0 Band neutrophil 0-5 1 0-5 Segmented neutrophil 54-71 63 52-72 *[Total neutrophils] 55-71 64 54-72 Eosinophil 0-6 3 0-7 Basophil 0-1 0 0-2 Lymphocyte 18-35 26 17-36 Atypical lymphocyte 0-6 0 0-9 Monocyte 1-8 5 1-8 Plasma cell 0-0 0 0-0 NRBC / 100 WBC 0-0 0 0-0 Cell Classification or Finding Expected Result Participant Results Anisocytosis None None ( 87%) Slight ( 13%) Moderate (0%) MarKed ( 0%) Poikilocytosis None None ( 95%) Slight ( 5%) Moderate (0%) MarKed ( 0%) Macrocytosis None None ( 94%) Slight ( 6%) Moderate (1%) MarKed ( 0%) Microcytosis None None ( 98%) Slight ( 2%) Moderate (0%) MarKed ( 0%) Hypochromia None None ( 97%) Slight ( 3%) Moderate (0%) MarKed ( 0%) Polychromasia None None ( 98%) Slight ( 2%) Moderate (0%) MarKed ( 0%) Reduced number of platelets Absent Absent( 96%) Present( 4%) Increased number of platelets Absent Absent( 99%) Present( 1%) Phagocytosis of platelet(s) Absent Absent(100%) Present( 0%) Bizarre or irregular platelets Absent Absent(100%) Present( 0%) Clumped platelets Absent Absent( 99%) Present( 1%) Giant platelets Absent Absent( 93%) Present( 7%) Platelet satellitosis Absent Absent(100%) Present( 0%) Auer rods Absent Absent(100%) Present( 0%) Dohle bodies Absent Absent(100%) Present( 0%) Hypersegmentation Absent Absent( 98%) Present( 2%) Pelger Huet anomaly Absent Absent(100%) Present( 0%) Smudge / Basket cells Absent Absent( 99%) Present( 1%) Toxic granulation Absent Absent( 96%) Present( 4%) Acanthocytes Absent Absent(100%) Present( 0%) Basophilic stippling Absent Absent( 99%) Present( 1%) Blister cells (pre keratocytes Absent Absent(100%) Present( 0%) Cabot rings Absent Absent(100%) Present( 0%) Echinocytes (crenated/burr cells) Absent Absent( 99%) Present( 1%) Elliptocytes (ovalocytes) Absent Absent( 93%) Present( 7%) Howell-Jolly bodies Absent Absent( 99%) Present( 1%) Pappenheimer bodies Absent Absent(100%) Present( 0%) Red cell agglutinates Absent Absent(100%) Present( 0%) Rouleaux Absent Absent( 98%) Present( 2%) Schistocytes Absent Absent(100%) Present( 0%) Schuffner's granules Absent Absent(100%) Present( 0%) Sickle cells (drepanocytes) Absent Absent(100%) Present( 0%) Spherocytes Absent Absent( 98%) Present( 2%) Stomatocytes Absent Absent(100%) Present( 0%) Target cells (codocytes) Absent Absent(100%) Present( 0%) Tear drop cells (dacrocytes) Absent Absent(100%) Present( 0%) Bacteria Absent Absent(100%) Present( 0%) Fungi/yeast Absent Absent(100%) Present( 0%) Malaria/Babesiosis Absent Absent(100%) Present( 0%) Stain precipitate Absent Absent(100%) Present( 0%) Phagocytosis of red cell(s) Absent Absent(100%) Present( 0%) * Obtained by combining individual results

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010 Slide 083 Available data: 49 year-old male Diagnosis: Aortic Disease WBC 25.6 x 10 9 /L RBC 3.43 x 10 12 /L Hemoglobin 10.0 g/dl Hematocrit 30.7 % MCV 89.5 fl Platelet count 339 x 10 9 /L The white blood cell count in this case was slightly elevated (25.6 x 10 9 /L) and few immature forms were present; myelocytes (participant median=3), metamyelocytes (participant median=5) and band forms (participant median=11). Echinocytes (Image 083), giant platelets and basophilic stippling were reported present by approximately half of the participants. The lack of consensus for these findings may be attributed to laboratory-specific reporting protocol.

Slide: 083 Cell Classification or Finding Expected Range Participant Median Participant Range Blast cell not classified 0-0 0 0-0 Myeloblast/Promyelocyte 0-1 0 0-2 Lymphoblast/Prolymphocyte 0-0 0 0-0 Monoblast/Promonocyte 0-0 0 0-0 Erythroblast 0-0 0 0-0 *[Myleblasts+Blasts not classified] 0-2 0 0-2 Lymphoma/Sezary cell 0-0 0 0-0 Hairy cell 0-0 0 0-0 Myelocyte 0-7 3 0-8 Metamyelocyte 0-10 5 0-10 Band neutrophil 3-25 11 2-28 Segmented neutrophil 50-78 66 49-78 *[Total neutrophils] 69-85 79 67-86 Eosinophil 0-2 0 0-2 Basophil 0-0 0 0-0 Lymphocyte 3-14 8 3-15 Atypical lymphocyte 0-2 0 0-2 Monocyte 0-8 4 0-9 Plasma cell 0-0 0 0-0 NRBC / 100 WBC 0-2 1 0-2 Cell Classification or Finding Expected Result Participant Results Anisocytosis Slight None ( 26%) Slight ( 54%) Moderate (19%) MarKed ( 1%) Poikilocytosis None None ( 56%) Slight ( 37%) Moderate ( 7%) MarKed ( 0%) Macrocytosis None None ( 57%) Slight ( 36%) Moderate ( 7%) MarKed ( 0%) Microcytosis None None ( 81%) Slight ( 14%) Moderate ( 5%) MarKed ( 0%) Hypochromia None None ( 66%) Slight ( 31%) Moderate ( 3%) MarKed ( 0%) Polychromasia Slight None ( 7%) Slight ( 65%) Moderate (27%) MarKed ( 0%) Reduced number of platelets Absent Absent( 99%) Present( 1%) Increased number of platelets Absent Absent( 79%) Present( 21%) Phagocytosis of platelet(s) Absent Absent(100%) Present( 0%) Bizarre or irregular platelets Absent Absent( 96%) Present( 4%) Clumped platelets Absent Absent( 86%) Present( 14%) Giant platelets Absent Absent( 60%) Present( 40%) Platelet satellitosis Absent Absent(100%) Present( 0%) Auer rods Absent Absent(100%) Present( 0%) Dohle bodies Absent Absent( 98%) Present( 2%) Hypersegmentation Absent Absent( 94%) Present( 6%) Pelger Huet anomaly Absent Absent( 99%) Present( 1%) Smudge / Basket cells Absent Absent( 83%) Present( 17%) Toxic granulation Absent Absent( 85%) Present( 15%) Acanthocytes Absent Absent( 95%) Present( 5%) Basophilic stippling Absent Absent( 52%) Present( 48%) Blister cells (pre keratocytes) Absent Absent(100%) Present( 0%) Cabot rings Absent Absent(100%) Present( 0%) Echinocytes (crenated/burr cells) Absent Absent( 51%) Present( 49%) Elliptocytes (ovalocytes) Absent Absent( 96%) Present( 4%) Howell-Jolly bodies Absent Absent( 98%) Present( 2%) Pappenheimer bodies Absent Absent(100%) Present( 0%) Red cell agglutinates Absent Absent(100%) Present( 0%) Rouleaux Absent Absent( 92%) Present( 8%) Schistocytes Absent Absent( 87%) Present( 13%) Schuffner's granules Absent Absent(100%) Present( 0%) Sickle cells (drepanocytes) Absent Absent(100%) Present( 0%) Spherocytes Absent Absent( 94%) Present( 6%) Stomatocytes Absent Absent( 99%) Present( 1%) Target cells (codocytes) Absent Absent( 97%) Present( 3%) Tear drop cells (dacrocytes) Absent Absent( 96%) Present( 4%) Bacteria Absent Absent(100%) Present( 0%) Fungi/yeast Absent Absent(100%) Present( 0%) Malaria/Babesiosis Absent Absent(100%) Present( 0%) Stain precipitate Absent Absent( 99%) Present( 1%) Phagocytosis of red cell(s) Absent Absent(100%) Present( 0%) * Obtained by combining individual results

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010 Slide 084 Available data: 84 year-old male Diagnosis: Aplastic Anemia WBC 2.3 x 10 9 /L RBC 3.23 x 10 12 /L Hemoglobin 9.7 g/dl Hematocrit 27.5. % MCV 85.2 fl Platelet count 23 x 10 9 /L The significant findings in this case of Aplastic Anemia were decreased number of white blood cells and thrombocytes. A reduced number of platelets was reported by 94% of participants. Elliptocytes, schistocytes and tear drop cells were observed. Most aplastic anemias (hypoplastic or aregenerative anemias) are caused by attrition or malfunction of the pluripotential stem cell known by the acronym CFU- GEMM. As the result of a shortage of these myeloid (marrow) stem cells, the marrow cavity is underpopulated with progeny of all three nonlymphoid hematopoietic cell lines: erythroblasts, granulocytes plus monocytes, and megakaryocytes ( trilineage aplasia ). The reduced total population of hematopoietic cells leads to pancytopenia, but the reduction in numbers of various blood cell types may be quite uneven. Jandle, J.H. Blood: Textbook of Hematology 2 nd Ed. Boston: Little, Brown and Company, 1996, p.201

Slide: 084 Cell Classification or Finding Expected Range Participant Median Participant Range Blast cell not classified 0-6 0 0-6 Myeloblast/Promyelocyte 0-0 0 0-0 Lymphoblast/Prolymphocyte 0-0 0 0-1 Monoblast/Promonocyte 0-0 0 0-0 Erythroblast 0-0 0 0-0 *[Blasts, all types] 0-6 0 0-7 Lymphoma/Sezary cell 0-0 0 0-0 Hairy cell 0-0 0 0-0 Myelocyte 0-1 0 0-2 Metamyelocyte 0-2 0 0-2 Band neutrophil 0-11 3 0-12 Segmented neutrophil 18-36 27 15-36 *[Total neutrophils] 23-40 31 22-41 Eosinophil 0-4 2 0-5 Basophil 0-1 0 0-1 Lymphocyte 45-70 59 43-71 Atypical lymphocyte 0-12 3 0-12 Monocyte 0-7 2 0-8 Plasma cell 0-0 0 0-0 NRBC / 100 WBC 0-2 0 0-2 Cell Classification or Finding Expected Result Participant Results Anisocytosis Slight None ( 14%) Slight ( 60%) Moderate (25%) MarKed ( 1%) Poikilocytosis Slight None ( 28%) Slight ( 60%) Moderate (13%) MarKed ( 0%) Macrocytosis None None ( 68%) Slight ( 28%) Moderate ( 5%) MarKed ( 0%) Microcytosis None None ( 49%) Slight ( 40%) Moderate (10%) MarKed ( 0%) Hypochromia None None ( 50%) Slight ( 40%) Moderate (10%) MarKed ( 0%) Polychromasia None None ( 77%) Slight ( 23%) Moderate ( 0%) MarKed ( 0%) Reduced number of platelets Present Absent( 6%) Present( 94%) Increased number of platelets Absent Absent(100%) Present( 0%) Phagocytosis of platelet(s) Absent Absent(100%) Present( 0%) Bizarre or irregular platelets Absent Absent( 99%) Present( 1%) Clumped platelets Absent Absent(100%) Present( 0%) Giant platelets Absent Absent( 86%) Present( 14%) Platelet satellitosis Absent Absent(100%) Present( 0%) Auer rods Absent Absent(100%) Present( 0%) Dohle bodies Absent Absent( 97%) Present( 3%) Hypersegmentation Absent Absent(100%) Present( 0%) Pelger Huet anomaly Absent Absent( 98%) Present( 2%) Smudge / Basket cells Absent Absent( 93%) Present( 7%) Toxic granulation Absent Absent( 94%) Present( 6%) Acanthocytes Absent Absent( 97%) Present( 3%) Basophilic stippling Absent Absent( 92%) Present( 8%) Blister cells (pre keratpcytes) Absent Absent( 98%) Present( 2%) Cabot rings Absent Absent(100%) Present( 0%) Echinocytes (crenated/burr cells) Absent Absent( 97%) Present( 3%) Elliptocytes (ovalocytes) Present Absent( 42%) Present( 58%) Howell-Jolly bodies Absent Absent(100%) Present( 0%) Pappenheimer bodies Absent Absent(100%) Present( 0%) Red cell agglutinates Absent Absent( 99%) Present( 1%) Rouleaux Absent Absent( 82%) Present( 18%) Schistocytes Absent Absent( 55%) Present( 45%) Schuffner's granules Absent Absent(100%) Present( 0%) Sickle cells (drepanocytes( Absent Absent(100%) Present( 0%) Spherocytes Absent Absent( 89%) Present( 11%) Stomatocytes Absent Absent(100%) Present( 0%) Target cells (codocytes) Absent Absent( 98%) Present( 2%) Tear drop cells (dacrocytes) Absent Absent( 54%) Present( 46%) Bacteria Absent Absent(100%) Present( 0%) Fungi/yeast Absent Absent(100%) Present( 0%) Malaria/Babesiosis Absent Absent(100%) Present( 0%) Stain precipitate Absent Absent( 99%) Present( 1%) Phagocytosis of red cell(s) Absent Absent(100%) Present( 0%) * Obtained by combining individual results

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010 Slide 085 Available data: 57 year-old male Diagnosis: CLL WBC 62.5 x 10 9 /L RBC 3.24 x 10 12 /L Hemoglobin 10.5 g/dl Hematocrit 31.0 % MCV 95.7 fl Platelet count 106 x 10 9 /L The significant finding in this case of Chronic Lymphocytic Leukemia (CLL) was the high percentage of mature lymphocytes (participant median =90). Smudge/Basket cells (Image 085) are abundant and were correctly reported by 99% of participants. Those participants who did not report the presence of smudge/basket cells received a comment that they should review the case. The Clinical and Laboratory Standards Institute (CLSI) document H20-A2 protocol for examining blood films states that, Except for certain forms associated with pathological states (e.g., chronic lymphocytic leukemia), less than 2% of the WBC should be disrupted or unidentifiable forms. The addition of albumin to the blood sample will decrease the fragility of the lymphocytes and decrease the formation of smudge cells.

Slide: 085 Cell Classification or Finding Expected Range Participant Median Participant Range Blast cell not classified 0-2 0 0-4 Myeloblast/Promyelocyte 0-0 0 0-0 Lymphoblast/Prolymphocyte 0-2 0 0-14 Monoblast/Promonocyte 0-0 0 0-0 Erythroblast 0-0 0 0-0 Lymphoma/Sezary cell 0-0 0 0-0 Hairy cell 0-0 0 0-0 Myelocyte 0-0 0 0-0 Metamyelocyte 0-0 0 0-0 Band neutrophil 0-2 0 0-2 Segmented neutrophil 1-12 6 1-12 *[Total neutrophils] 1-12 6 1-12 Eosinophil 0-1 0 0-1 Basophil 0-0 0 0-0 Lymphocyte 75-98 90 0-98 Atypical lymphocyte 0-19 0 0-23 Monocyte 0-3 1 0-3 Plasma cell 0-0 0 0-0 NRBC / 100 WBC 0-0 0 0-0 Cell Classification or Finding Expected Result Participant Results Anisocytosis Slight None ( 49%) Slight ( 49%) Moderate ( 2%) MarKed ( 1%) Poikilocytosis None None ( 72%) Slight ( 27%) Moderate ( 0%) MarKed ( 0%) Macrocytosis None None ( 78%) Slight ( 19%) Moderate ( 3%) MarKed ( 0%) Microcytosis None None ( 88%) Slight ( 10%) Moderate ( 2%) MarKed ( 0%) Hypochromia None None ( 87%) Slight ( 13%) Moderate ( 0%) MarKed ( 0%) Polychromasia None None ( 87%) Slight ( 12%) Moderate ( 1%) MarKed ( 0%) Reduced number of platelets Present Absent( 34%) Present( 66%) Increased number of platelets Absent Absent(100%) Present( 0%) Phagocytosis of platelet(s) Absent Absent(100%) Present( 0%) Bizarre or irregular platelets Absent Absent(100%) Present( 0%) Clumped platelets Absent Absent( 99%) Present( 1%) Giant platelets Absent Absent( 98%) Present( 2%) Platelet satellitosis Absent Absent(100%) Present( 0%) Auer rods Absent Absent(100%) Present( 0%) Dohle bodies Absent Absent(100%) Present( 0%) Hypersegmentation Absent Absent(100%) Present( 0%) Pelger Huet anomaly Absent Absent(100%) Present( 0%) Smudge / Basket cells Present Absent( 1%) Present( 99%) Toxic granulation Absent Absent( 98%) Present( 2%) Acanthocytes Absent Absent(100%) Present( 0%) Basophilic stippling Absent Absent( 99%) Present( 1%) Blister cells (pre keratocytes) Absent Absent(100%) Present( 0%) Cabot rings Absent Absent(100%) Present( 0%) Echinocytes (crenated/burr cells) Absent Absent( 98%) Present( 2%) Elliptocytes (ovalocytes) Absent Absent( 74%) Present( 26%) Howell-Jolly bodies Absent Absent(100%) Present( 0%) Pappenheimer bodies Absent Absent(100%) Present( 0%) Red cell agglutinates Absent Absent(100%) Present( 0%) Rouleaux Absent Absent( 95%) Present( 5%) Schistocytes Absent Absent( 98%) Present( 2%) Schuffner's granules Absent Absent(100%) Present( 0%) Sickle cells (drepanocytes) Absent Absent(100%) Present( 0%) Spherocytes Absent Absent( 89%) Present( 11%) Stomatocytes Absent Absent(100%) Present( 0%) Target cells (codocytes) Absent Absent(100%) Present( 0%) Tear drop cells (dacrocytes) Absent Absent( 94%) Present( 6%) Bacteria Absent Absent(100%) Present( 0%) Fungi/yeast Absent Absent(100%) Present( 0%) Malaria/Babesiosis Absent Absent(100%) Present( 0%) Stain precipitate Absent Absent( 99%) Present( 1%) Phagocytosis of red cell(s) Absent Absent(100%) Present( 0%) * Obtained by combining individual results